跳至主要内容
临床试验/NCT05416320
NCT05416320撤回早期 1 期

A Pilot Study of Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家开始时间: 2023年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
撤回
试验地点
1
主要终点
Amount of hairline stabilization

研究概览

简要总结

The purpose of this pilot study is to determine if calcipotriol shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). This study aims to evaluate calcipotriol due to the possible anti-inflammatory effects that may affect the hair growth cycle.

详细描述

Calcipotriol, a vitamin D analog, has been topically used to treat alopecia areata, a form of non-scarring autoimmune alopecia in several studies. It is possible that Vitamin D plays a role in sustaining the hair follicle's immune privilege through anti-inflammatory effects such as controlling Interferon gamma (IFN-γ) production. A recent study showed a significant decrease of vitamin D in Black patients with Central Centrifugal Cicatricial Alopecia (CCCA)"

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women who are eighteen years of age or older
  • biopsy-proven and/or clinical diagnosis of CCCA Stage II-IV
  • must be on stable treatment without changes for at least 3 months
  • Subjects will be recruited from outpatient dermatology clinics at the Wake Forest Baptist Health Department of Dermatology.

排除标准

  • 未提供

研究组 & 干预措施

Calcipotriol Group

Experimental

Subjects will use the topical formulation once daily on the scalp. The subjects will use the treatment for a total of 6 months.

干预措施: Calcipotriol (Drug)

Control Group

Sham Comparator

Subjects will continue to use their primary physician prescribed topical formulation once daily on the scalp. The subjects will use their treatment for a total of 6 months.

干预措施: Subject's already prescribed drug (Drug)

结局指标

主要结局

Amount of hairline stabilization

时间窗: Month 6

Standardized camera and dermatoscopic photographs

次要结局

  • Signs and symptoms of disease score(Month 2, Month 4, and Month 6)
  • Dermatology Life Quality Index score(Baseline and Month 6)
  • Amount of hair regrowth(Baseline, Month 2, Month 4, and Month 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Calcipotriol as a Novel Treatment for Central... | 临床试验